NDAORALTABLET
Approved
Jul 1984
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20
Clinical Trials (5)
Vorapaxar and Lower Extremity Bypass Grafts
Started Oct 2017
0Peripheral Artery Disease
Research Study Comparing a New Medicine "Fast-acting Insulin Aspart" to Another Already Available Medicine "NovoRapid"/"NovoLog" in People With Type 2 Diabetes
Started Sep 2017
1,264 enrolled
DiabetesDiabetes Mellitus, Type 2
Comparison of SAR341402 to NovoLog/NovoRapid in Adult Patients With Diabetes Mellitus Also Using Insulin Glargine
Started Aug 2017
597 enrolled
Type 1 Diabetes Mellitus-Type 2 Diabetes Mellitus
Efficacy and Safety of Continuous Subcutaneous Insulin Infusion of Faster-acting Insulin Aspart Compared to NovoRapid® in Adults With Type 1 Diabetes
Started Jul 2016
472 enrolled
DiabetesDiabetes Mellitus, Type 1
Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Adults With Type 1 Diabetes
Started May 2016
1,108 enrolled
DiabetesDiabetes Mellitus, Type 1